World Infectious Disease Testing Market

This unique 92-country report from provides granular data and analyses not available from any other source, including:
- Supplier shares by product and country
- Volume and sales forecasts for individual tests, market segment and country
- Competitor strategies and SWOT analyses.
The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.
The report is available by section, and can be customized to specific information needs and budget.
The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.
The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces are advances in molecular diagnostic technologies; threat of bioterrorism; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam

Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine

Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

North America
Canada, Mexico, USA
Market Segmentation Analysis
- Sales and market shares of major suppliers of infectious disease diagnostic products in major countries by test.
- Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:
- Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products
- In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review
- Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.
- Companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers
- Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.


Competitive Assessments
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Decode Genetics
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujifilm Wako
- Fujirebio
- Grifols
- Hologic
- Illumina
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- OrthoQuidel
- PerkinElmer
- Proteome Sciences
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom/LabCorp
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher


I. Introduction

II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Worldwide Overview of Major Tests,
Technologies and Instrumentation

A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia
Table of Contents (continued)
16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakobs Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis
63. Salmonellosis
64. Septicemia
65. Shigellosis
66. Staphylococcus Aureus
67. Streptococci
68. Syphilis
69. Toxoplasmosis
70. Trichomonas Vaginalis
71. Tuberculosis
72. Vibrio
73. West Nile Virus
74. Yersina

VII. Country Market Analyses: Infectious Disease Screening Test
Volume and Sales Forecasts for 92 Countries

Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil,
Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic,
Denmark, Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia,
Germany, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia,
Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon,
Lithuania, Malaysia, Malta, Mexico, Moldova, Myanmar, Netherlands, New Zealand, Nicaragua,
Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico,
Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea,
Spain,
Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, Ukraine, United Arab Emirates, Uruguay,
USA, Venezuela, Vietnam













































List Of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests

Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests

Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests

All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bangladesh
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Albania
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Albania
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Argentina
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Argentina
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Australia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Australia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Austria
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Austria
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Bahrain
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bahrain
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Bangladesh

All Market Segments Infectious Disease
Test Volume Forecast by Assay
Canada
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Belarus
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Belarus
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Belgium
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Belgium
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Bolivia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bolivia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Brazil
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Brazil
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Bulgaria
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bulgaria
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Canada

All Market Segments Infectious Disease
Test Volume Forecast by Assay
Cuba
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Chile
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Chile
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
China
All Market Segments Infectious Disease
Test Volume Forecast by Assay
China
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Colombia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Colombia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Costa Rica
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Costa Rica
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Croatia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Croatia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Cuba

All Market Segments Infectious Disease
Test Volume Forecast by Assay
El Salvador
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Cyprus
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Cyprus
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Czech Republic
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Czech Republic
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Denmark
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Denmark
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Dominican Republic
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Dominican Republic
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Ecuador
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Ecuador
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
El Salvador

Test Volume Forecast
France
All Market Segments Infectious Disease Diagnostics
Market Forecast
Estonia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Estonia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Finland
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Finland
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
France
Laboratories Performing Infectious Disease Tests by Market Segment
France
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
France
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
France

World Nucleic Acid Testing Market Opportunities in 92 Countries

World Nucleic Acid Testing Market Opportunities in 92 CountriesThis new 92-country survey provides granular data and analysis not available from any other source.The report is designed to help current suppliers

USD 34500 View Report

Whats Next for World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market?

Whats Next for World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketThe report is available by section, market segment, and can be customized to your specific information needs and

USD 24500 View Report

Vietnam Blood Typing, Grouping and Infectious Disease

Vietnam Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023-2028 Volume and Sales Segment ForecastsThis unique report provides information and analysis not available from any other published source.The report is

USD 850 View Report

Venezuela Blood Typing, Grouping and Infectious Disease

Venezuela Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023-2028 Volume and Sales Segment ForecastsThis unique report provides information and analysis not available from any other published source.The report is

USD 850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available